Miscellanous Flashcards
Which of the following is/are TRUE about official New York State Prescription forms?
I. Official New York State Rx forms shall be imprinted only with the primary address and other addresses listed on the registration of the facility or practitioner.
II. The number of official prescription forms or facility labels issued to a registered practitioner or registered facility at any time shall be at the discretion of the department.
III. Official New York State prescription forms issued to a practitioner may be used only by the practitioner(s) to whom they are issued.
IV. Official prescriptions or facility labels issued to a facility may be used by staff practitioners only for patients of the registered facility.
Registered practitioners and registered facilities shall notify the department immediately upon:
their knowledge of the loss, destruction, theft or unauthorized use of any official New York State prescription forms, as well as the failure to receive official New York State prescription forms within a reasonable time after ordering them from the department.
Practitioners shall immediately notify the Bureau of Narcotic Enforcement if:
I) his/her credentials used to sign electronic prescriptions for controlled substances have been lost, stolen or compromised.
II) one or more Rxs issued under that practitioner’s DEA registration were Rxs the practitioner had not signed or were not consistent with the Rx the practitioner signed.
When a patient’s health care provider prescribes a prescription drug that is not on the preferred drug list or not on the statewide formulary of opioid dependence agents and opioid antagonists, the prescriber shall consult with the program to confirm that in his or her reasonable professional judgment, the patient’s clinical condition is consistent with the criteria for approval of the non-preferred drug. Such criteria shall include:
(i) . the preferred drug has been tried by the patient and has failed to produce the desired health outcomes;
(ii) . the patient has tried the preferred drug and has experienced unacceptable side effects;
(iii) . the patient has been stabilized on a non-preferred drug and transition to the preferred drug would be medically contraindicated; or
(iv) . other clinical indications identified by the drug utilization review board, which shall include consideration of the medical needs of special populations, including children, elderly, chronically ill, persons with mental health conditions, and persons affected by HIV/AIDS, pregnant persons, and persons with an opioid use disorder.
The preferred drug program shall make available a 24 hr per day, 7 days per week telephone call center that includes a toll-free telephone line and dedicated facsimile line to respond to requests for prior authorization and the call center shall include…
qualified health care professionals who shall be available to consult with prescribers concerning prescription drugs that are not on the preferred drug list. A prescriber seeking a PA shall consult with the program call line to reasonably present his or her justification for the prescription and give the qualified health care professional a reasonable opportunity to respond.
“Telehealth” means the use of electronic information and communication technologies by telehealth providers to…
deliver health care services, which shall include the assessment, diagnosis, consultation, treatment, education, care management and/or self-management of a patient.
Under the New York State Pharmacy Law, who can order remote patient monitoring?
a licensed physician, a licensed nurse practitioner, or a licensed midwife with whom the patient has a substantial and ongoing relationship.
A pharmacy that is part of a group of eight or more pharmacies, located within New York State and owned by the same corporate entity, is known as…
a “covered pharmacy.” For purposes of this section, “corporate entity” shall include related subsidiaries, affiliates, successors, or assignees doing business as or operating under a common name or trading symbol.
A practitioner shall not be required to issue prescriptions electronically if he or she certifies to the department of health that he or she will not issue more than…
25 prescriptions during a twelve-month period. Prescriptions in both oral and written form for both controlled substances and non-controlled substances shall be included in determining whether the practitioner will reach the limit.
Which of the following are Schedule A poisons?
arsenic, atropine, corrosive sublimate, potassium cyanide, chloral hydrate, hydrocyanic acid, strychnine
(and all other poisonous vegetable alkaloids and their salts and oil of bitter almond containing hydrocyanic acid)
Which of the following are Schedule B poisons?
aconite, belladonna, cantharides, colchicum, conium cotton root, digitalis, ergot, hellebore, henbane… etc. or any drug, chemical, or preparation which is liable to be destructive to adult human life in quantities of 60 grains or less.
It shall be unlawful for any person to sell at retail or to furnish any of the poisons of Schedule A and B without affixing or causing to be affixed to the bottle, box, vessel or package, a label with the name of the article and the word…
“poison” directly shown and with the name and place of business of the seller all printed in “red ink” together with the name of such poisons printed or written in plain, legible characters.
Healthcare facilities such as hospitals may return unused medications and redispense them if:
(i) it has its own pharmacy
(ii) in which unit-dose medication is dispensed to inpatients
(iii) each dose is individually sealed and labeled with: the name of the drug, dosage strength, the manufacturer’s lot/control #, and expiration date
AND the facility may redispense the medication;
A private practice physician may employ or supervise up to how many physician assistants?
No more than 4 PAs and 2 registered specialist assistants
Medications dispensed by a practitioner should have the following included on the container label:
(i) name and address of the dispenser
(ii) the name and address of the patient
(iii) delivery date
(iv) drug name and strength
(v) directions for use
